These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9108818)

  • 41. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of intravenous valproate in psychiatry.
    Norton J
    Can J Psychiatry; 2001 May; 46(4):371-2. PubMed ID: 11387798
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
    Potter WZ; Ketter TA
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S51-6. PubMed ID: 8500079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valproic Acid and hypersensitivity syndrome.
    Roepke S; Treudler R; Anghelescu I; Orfanos CE; Tebbe B
    Am J Psychiatry; 2004 Mar; 161(3):579. PubMed ID: 14992991
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetics of valproic acid in patients with bipolar disorder.
    Vasudev K; Das S; Goswami U; Tayal G
    J Psychopharmacol; 2001 Sep; 15(3):187-90. PubMed ID: 11565626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-dependent valproate-induced alopecia in patients with mental disorders.
    Tomita T; Goto H; Yoshida T; Tanaka K; Sumiya K; Kohda Y
    Indian J Pharmacol; 2015; 47(6):690-2. PubMed ID: 26729968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A rare occurrence of isolated neutropenia with valproic acid: a case report.
    Chakraborty S; Chakraborty J; Mandal S; Ghosal MK
    J Indian Med Assoc; 2011 May; 109(5):345-6. PubMed ID: 22187773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can we prevent fatal liver failure under valproate?
    Schmid MM; Connemann BJ; Wolf RC; Flechtenmacher C; Eisenbach C; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2010 Jul; 43(5):198-200. PubMed ID: 20503151
    [No Abstract]   [Full Text] [Related]  

  • 50. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 51. Abnormal semen parameters in bipolar men treated with valproate.
    Aldemir E; Arici Ş; Umul M; Öztürk U; Aydin HH; Çelebisoy M; Vahip S
    Turk Psikiyatri Derg; 2012; 23(2):145-6. PubMed ID: 22826831
    [No Abstract]   [Full Text] [Related]  

  • 52. Visual and auditory hallucinations with the association of bupropion and valproate.
    Filteau MJ; Leblanc J; Lefrançoise S; Demers MF
    Can J Psychiatry; 2000 Mar; 45(2):198-9. PubMed ID: 10742884
    [No Abstract]   [Full Text] [Related]  

  • 53. Valproate-induced tinnitus misinterpreted as psychotic symptoms.
    Reeves RR; Mustain DW; Pendarvis JE
    South Med J; 2000 Oct; 93(10):1030-1. PubMed ID: 11147471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valproate and babies.
    Whitehall J; Smith J
    Aust N Z J Psychiatry; 2008 Sep; 42(9):837. PubMed ID: 18696289
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnesium valproate-induced pedal edema on chronic therapy: A rare adverse drug reaction.
    Prajapati H; Kansal D; Negi R
    Indian J Pharmacol; 2017; 49(5):399-400. PubMed ID: 29515282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anemia, neutropenia and thrombocytopenia: hematological findings and HIV].
    Wolf K; Tichelli A; Battegay M
    Praxis (Bern 1994); 2001 Oct; 90(41):1775-9. PubMed ID: 11692792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 59. The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.
    Buoli M; Serati M; Botturi A; Altamura AC
    Drugs R D; 2018 Mar; 18(1):1-5. PubMed ID: 29260458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N; Landry KB; Fargason RE; Birur B
    Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.